(1)
Wen, S.; Zeng, J.; Zhong, L.; Ye, J.; Lai, X. The Efficacy and Adverse Effects of Nivolumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma: Nivolumab and Lenvatinib in the Treatment of HCC. Cell Mol Biol (Noisy-le-grand) 2022, 68, 53-57.